Top Markets
Coin of the day
Bioasis Technologies Inc. Bioasis Technologies Inc.

Bioasis Technologies Inc.

BTI
Clasificación en acciones #39945
Bioasis Technologies Inc. is a development-stage biopharmaceutical firm focused... Bioasis Technologies Inc. is a development-stage biopharmaceutical firm focused on innovating diagnostic methods and therapeutic solutions for a range of neurological conditions. The company's primary technological asset is the xB3 platform, engineered to enable the transport of medicinal compounds across the often-impenetrable blood-brain barrier. This capability is crucial for addressing central nervous system disorders, including various brain cancers, metabolic dysfunctions, and neurodegenerative illnesses. Bioasis is actively advancing its in-house pipeline with programs such as xB3-001 for brain metastases, xB3-002 for glioblastoma, and xB3-007 for neurodegenerative diseases, all designed to offer both symptomatic relief and disease-modifying benefits. The company has also established numerous strategic alliances. These include a partnership with Aposense Limited to deliver siRNA therapeutics for CNS disorders; a collaboration with Oxyrane UK Ltd. to combine the xB3 technology with Oxyrane's OxyCAT platform for enhanced enzyme replacement therapy targeting the brain; an agreement with Janssen Biotech, Inc. for the discovery, development, and commercialization of novel products leveraging the xB3 platform; and a research and licensing deal with Neuramedy Co Ltd. to develop and market an xB3-enhanced version of their antibody, Tomaralimab. Founded in 2006, Bioasis Technologies Inc. is headquartered in New Haven, Connecticut.
Precio por acción
$0.00366968
Última sincronización: 2024-07-23
Capitalización bursátil
$291.42K
Cambio (1 día)
-0.81%
Cambio (1 año)
0.00%
País
US
Comercio Bioasis Technologies Inc. (BTI)

Categoría

Precio BTI con Capital del mercado a B
Bioasis Technologies Inc. Bioasis Technologies Inc.
BTI
$0.00366968
Capitalización de mercado de Bioasis Technologies Inc.(BTI)
Capitalización bursátil: $291.42K
A fecha de August 2026, Bioasis Technologies Inc. tiene una capitalización de mercado de $291.42K. Esto convierte a Bioasis Technologies Inc. en la 39945th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Bioasis Technologies Inc. desde 2008 hasta 2026
BTI en comparación con los más populares 5 títulos stocks
Precio por BTI Activo B Capital del mercado en B Resultados
Bioasis Technologies Inc. Bioasis Technologies Inc.
$68,873.72 $291.42K
$5.470T +1,876,829,455.54%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$56,250.42 $291.42K
$4.467T +1,532,840,809.29%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$52,564.87 $291.42K
$4.174T +1,432,408,272.84%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$46,592.25 $291.42K
$3.700T +1,269,652,791.00%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$35,942.56 $291.42K
$2.854T +979,445,505.37%